tezosentan has been researched along with Blood Pressure, Low in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hjelmqvist, H; Sollevi, A; Somell, A; Suneson, A; Weitzberg, E | 1 |
| Caspi, A; Cotter, G; Jafari, J; Kaluski, E; Kiowski, W; Kobrin, I; Krakover, R; Marmor, A; Milovanov, O; Reisin, L; Vered, Z | 1 |
1 trial(s) available for tezosentan and Blood Pressure, Low
| Article | Year |
|---|---|
Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steep decrease in blood pressure in patients with congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Endothelin Receptor Antagonists; Female; Follow-Up Studies; Heart Failure; Heart Function Tests; Humans; Hypotension; Infusions, Intravenous; Male; Middle Aged; Probability; Pyridines; Receptors, Endothelin; Reference Values; Severity of Illness Index; Stroke Volume; Tetrazoles; Treatment Outcome; Vascular Resistance | 2001 |
1 other study(ies) available for tezosentan and Blood Pressure, Low
| Article | Year |
|---|---|
Effects of the dual endothelin receptor antagonist tezosentan and hypertonic saline/dextran on porcine endotoxin shock.
Topics: Acid-Base Equilibrium; Acidosis; Animals; Blood Circulation; Blood Pressure; Dextrans; Drug Therapy, Combination; Endothelin Receptor Antagonists; Endotoxins; Escherichia coli; Female; Hypotension; Male; Pulmonary Gas Exchange; Pyridines; Random Allocation; Saline Solution, Hypertonic; Shock, Septic; Swine; Tetrazoles; Vasodilation | 2007 |